OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Humaid Al-Shamsi: KHCC’s Role in Advancing Cancer Research Across the Arab World

Amanda Pullinger: Bringing East and West Together to Improve the Gastric Cancer Patient Journey

Caregiver Burnout – An Unrecognised Challenge in Oncology

10 Must-Read Posts In GI Oncology This Week

Anjali Sibley and Angelina Lorello at COGC 2026: Remember Your Why, Keep the Patient at the Center

Oncology News, Insights, Stories by OncoDaily

Madrid Midnight OncoDaily Party
Projects

OncoDaily Party 2026: Madrid Midnight

ASCOQLTY26,
Not To Miss

20 Posts Not To Miss From ASCOQLTY26

NSCLC
Lung Oncology

Oncogene-Driven NSCLC in 2026: Targeted Therapy Expands Across Mutations, Resistance and CNS Disease

Stronger Through Connection: Why Lived Experience Belongs at the Heart of the EU Cancer Mission

ESMO 2026: 10 Breast Cancer ADCs to Watch in Madrid

ENERGIZE Trial: Can Immunotherapy Improve Perioperative Treatment in MIBC?

Pat Garcia-Gonzalez: Max’s Day Is a Reminder of All That Is Good in the World

Can Live Tumor Biopsies Predict Immunotherapy Response?

At What Stage of Cancer Is Chemotherapy Used? A Stage-by-Stage Guide

Enrique Grande: Rethinking Research Priorities Across Prostate, Kidney and Bladder Cancer

Voices
Randall Kimple

Randall Kimple Highlights the Teamwork Behind Cancer Research

Alicia Fong: Exploring the Role of AI in Cancer Detection and Treatment

From Patient Voice to Better Evidence in Liver Cancer – ELPA

"Breaking the bureaucracy at WHO. Mechanism one: no empty desks" - Dr Gevorg Tamamyan

15 Days Left to Register For the 2026 Global CRC Congress - Global Colon Cancer Association

Opportunity to Join the CGI-Clinics Symposium on Clinical Insights in Cancer Genome Interpretation - EACR

Gilberto Lopes: Advancing Global Cancer Control Through Evidence, Policy, and Partnership

FDA Approvals
CLL/SLL Pirtobrutinib

FDA Approves Pirtobrutinib for First-Line CLL/SLL Without 17p Deletion, a First for Non-Covalent BTK Inhibitors

Teva Receives U.S. FDA Approval for Denosumab Biosimilar for Oncology Indications

Niklas Klümper: FDA Approves Belzutifan Plus Lenvatinib in Advanced ccRCC

FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer

FDA Approves Taletrectinib Label Update With 49.7-Month Duration of Response in ROS1+ NSCLC

FDA Approves Curium’s Bexlutry (Lutetium Lu 177) for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

FDA Approves Floretyrosine F 18 for PET Imaging in Glioma

OncoDaily 100
100 Influential Women

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

100 Influential Women in Oncology in 2026: Key Opinion Leaders in Social Media and Beyond

Celebrities and Cancer

OncoCalendar

ESTRO - Evidence Based Radiation Oncology

European Society for Radiotherapy and Oncology (ESTRO)

19 Oct
Radiation Oncology

VIDAWASI International Medical Congress 2026

VIDAWASI PERÚ

20 Oct
VIDAWASI

Association of Cancer Care Centers (ACCC) 43rd National Oncology Conference

Association of Cancer Care Centers

21 Oct
Association of Cancer Care Centers

Kidney Week 2026

American Society of Nephrology (ASN)

21 Oct
Kidney Week 2026

The Best of IMS Europe Webinar

International Myeloma Society (IMS)

21 Oct
IMS Asia Pacific Webinar

ESSO - Advanced Course on Breast Cancer Surgery

22 Oct
Breast Cancer Surgery

ESSO - Advanced Course on Pancreatic Cancer Surgery

European Society of Surgical Oncology

22 Oct
Pancreatic Cancer Surgery

6th European Congress on Cancer and Oncology Research - UICC

Coalesce Research Group

22 Oct
Cancer and Oncology Research

64th Annual Meeting of the Japan Society of Clinical Oncology (JSCO 2026)

Japan Society of Clinical Oncology

22 Oct
Japan Society of Clinical Oncology

50th International Conference on Screening for Lung Cancer and 18th Conference on Research for Early Lung Cancer Treatment

International Early Lung Cancer Action Program

22 Oct
Lung Cancer

The WVOS 2026 Fall Conference

West Virginia Oncology Society

22 Oct
WVOS 2026

Immune-oncology
ENERGIZE Trial: Can Immunotherapy Improve Perioperative Treatment in MIBC?

ENERGIZE Trial: Can Immunotherapy Improve Perioperative Treatment in MIBC?

Can Live Tumor Biopsies Predict Immunotherapy Response?

KEYNOTE-966: Does Pembrolizumab Make Responses More Durable in Biliary Tract Cancer?

Can Distant Lymph Nodes Sustain Immunotherapy After Lymph-Node Surgery?

BioNTech Shares Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy in Metastatic HPV16-Positive HNC

DECIDE-MET Trial: Targeted Therapy or Immunotherapy First in METex14 NSCLC?

KEYNOTE-B49 at ESMO 2026: Can Immunotherapy Find a Role in HR+/HER2− Breast Cancer?

Gastrointestinal-Oncology
GI Oncology

10 Must-Read Posts In GI Oncology This Week

3D Models and Tissue Engineering for Colorectal Cancer Drug Screening

Daraxonrasib Receives Positive CHMP Opinion for Previously Treated Metastatic Pancreatic Cancer

5 Pancreatic Cancer Trials to Watch at ESMO 2026

FFCD-AC: 1L Chemotherapy for Metastatic Recurrence of Ampullary Adenocarcinoma

Phase 3b SIERRA: Durvalumab Plus Tremelimumab in Poor-Prognosis Unresectable HCC

Phase 1b/2 HERBOT Trial: First-Line HER2-Targeted Chemoimmunotherapy in Biliary Tract Cancer

Breast-Oncology
Breast Cancer

Premenopausal HR+/HER2− Early Breast Cancer: Where Evidence Still Falls Short in Adjuvant Care

ESMO 2026: 10 Breast Cancer ADCs to Watch in Madrid

HELEN-Trio 011: Camrelizumab Improves pCR With Anthracycline-Free Neoadjuvant Therapy in Stage II–III TNBC

ESMO 2026 Metastatic Breast Cancer Guideline: Biomarker-Driven Therapy Reshapes Treatment Across Subtypes

MAMMÔ 2026: Precision, De-Escalation and New Treatment Sequencing Reshape Breast Cancer Care

Can Maintenance HER2 Therapy Be Stopped? Global Survey Reveals Clinical Equipoise in Long-Term Responders

NRG-BR002: Metastasis-Directed Ablation Fails to Improve PFS or OS in Oligometastatic Breast Cancer

Lung-Oncology
NSCLC

Oncogene-Driven NSCLC in 2026: Targeted Therapy Expands Across Mutations, Resistance and CNS Disease

ESMO 2026: 10 ADCs in Lung Cancer to Watch

FURTHER: Firmonertinib Shows Promising Activity in EGFR PACC-Mutant Advanced NSCLC

LIGHT-NING: Real-World Nivolumab Plus Ipilimumab Shows Durable Outcomes in Metastatic NSCLC

Jazz EMERGE 402: Real-World Lurbinectedin Shows Clinically Meaningful Activity in Previously Treated SCLC

AENEAS2: Aumolertinib Plus Chemotherapy Extends PFS in EGFR-Mutant Advanced NSCLC

Unresectable Stage III NSCLC: PACIFIC Remains the Backbone as Precision Strategies Reshape Care

OncoDaily TV
Rachel Purcell

Rachel Purcell Highlights New Zealand’s Nationwide Exercise Program for Bowel Cancer Patients

Alicia Fong

Alicia Fong: Exploring the Role of AI in Cancer Detection and Treatment

Dr Gevorg Tamamyan

“Stronger Regions, Stronger Countries…” – Dr Gevorg Tamamyan

Rejin Kebudi

“Diligent, Intelligent, Capable of Reaching Many Colleagues Globally ” – Rejin Kebudi, General Secretary of the International Society of Pediatric Oncology, about Dr Gevorg Tamamyan Upon His WHO DG Candidacy

Dr. Gevorg Tamamyan

“One of the Most Amazing and Truly Legendary Oncologists of Our Time” – Dr. Gevorg Tamamyan on Dr. Julie Gralow, Chief Medical Officer of ASCO

Dr Gevorg Tamamyan

“I Still Remember His Mentees That Spoke So Highly of Him… Having a Vision Means Investing in People That Will Make a Difference For the Years to Come” – Albanian Hematologist Liri Seraj Supports Dr Gevorg Tamamyan as WHO DG Candidate

World Radiotherapy Awareness Day

12 Countries, One Vision for the Future of Radiotherapy – World Radiotherapy Awareness Day

Bishal Gyawali

Erika Ruiz-Garcia Joins Bishal Gyawali on Grounded In Groundshot Podcast

Dr Gevorg Tamamyan

“One Planet is Not Enough For His Vision” – Dr Amalya Sargsyan Celebrates Her Mentor Dr Gevorg Tamamyan

Dr Gevorg Tamamyan

Renowned Surgeon and Inventor of Abraxane, Philanthropist Dr Patrick Soon-Shiong Endorses Dr Gevorg Tamamyan as WHO Director-General Candidate

Burnout

Oncology Beyond Guidelines: Burnout, Imposter Syndrome, Mentorship & Cancer Prevention with Imène Hadji

Holistic Healing

Cancer Survivorship, Holistic Healing and Patient Advocacy with Rohini Singh Sisodia

Not To Miss
ASCOQLTY26,

20 Posts Not To Miss From ASCOQLTY26

Parker Institute Investigators’ Startups Azalea and Medici Named to 2026 Endpoints 11

Breast Health Day 2026: Why Early Detection Matters and Why Screening Cannot Wait

Legend Biotech Receives FDA IND Clearance for LB2501, a CD19/CD20 In Vivo CAR-T Therapy

Merck at ESMO 2026: Phase 3 mRNA, TROP2 ADC and Pembrolizumab Data Lead 90+ Abstracts

RYZ101 Improves PFS in Phase 3 ACTION-1 Trial for GEP-NETs After Lutetium-177 Therapy

15 Posts Not To Miss From DCLung26

OncoGrants
Molecular Oncology

EACR–Molecular Oncology Editorial Fellowship 2027

Y-ESSO Research

Y-ESSO Research Grants for Young Surgical Oncologists 2026

John Robert Lewis

AACR-Lustgarten Foundation Career Development Award for Pancreatic Cancer Research - in Honor of John Robert Lewis 2027

Melanoma Research

Melanoma Research Alliance Young Investigator Award 2026–2027

Graduate Hematology Award

ASH Graduate Hematology Award 2027

ASTRO–ACS

ASTRO–ACS Clinician Scientist Development Grant 2026

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: Current Practice and Evolving Directions

CancerWorld

Oncologists
Loizos G. Loizou

Loizos G. Loizou

Oncologists Location Nicosia, Cyprus
Herdee Gloriane C. Luna

Herdee Gloriane C. Luna

Oncologists Location Quezon City, Philippines
Airazat Kazaryan

Airazat Kazaryan

Oncologists Location Grålum, Norway
Sara Lonardi

Sara Lonardi

Oncologists Location Padua, Italy
Alberto Puccini

Alberto Puccini

Oncologists Location Milan, Italy
Nabiel Mir

Nabiel Mir

Oncologists Location Chicago, USA
C.S. Pramesh

C.S. Pramesh

Oncologists Location Mumbai, India
Mary Gospodarowicz

Mary Gospodarowicz

Oncologists Location Toronto, Canada

Drugs Atlas
Lenvatinib (Lenvima): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in Thyroid Cancer, RCC, HCC, and Endometrial Cancer Lenvatinib (Lenvima) Oct 18, 2026 2:06 pm
Regorafenib (Stivarga): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in Colorectal Cancer, GIST, and Hepatocellular Carcinoma Regorafenib (Stivarga) Oct 18, 2026 2:05 pm
Sorafenib (Nexavar): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in HCC, RCC, and Differentiated Thyroid Cancer Sorafenib (Nexavar) Oct 18, 2026 2:14 am
Pazopanib: Understanding Its Mechanism, Dosing, Clinical Uses, and Role in Renal Cell Carcinoma and Soft Tissue Sarcoma Pazopanib Oct 18, 2026 2:13 am
Axitinib (Inlyta): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in Advanced Renal Cell Carcinoma Axitinib (Inlyta) Oct 18, 2026 2:10 am
Cabozantinib: Understanding Its Mechanism, Dosing, Clinical Uses, and Role in RCC, HCC, Thyroid Cancer, and Neuroendocrine Tumors Cabozantinib Oct 18, 2026 2:09 am
Tucatinib (Tukysa): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in HER2-Positive Breast Cancer and Colorectal Cancer Tucatinib (Tukysa) Oct 15, 2026 1:47 pm
Sunitinib (Sutent): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in RCC, GIST, and Pancreatic Neuroendocrine Tumors Sunitinib (Sutent) Oct 15, 2026 1:45 pm
Lapatinib (Tykerb): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in HER2-Positive Breast Cancer Lapatinib (Tykerb) Oct 14, 2026 4:57 am
Neratinib (Nerlynx): Understanding Its Mechanism, Dosing, Clinical Uses, and Role in HER2-Positive Breast Cancer Neratinib (Nerlynx) Oct 14, 2026 4:56 am

OncoDaily Magazine

New Paper Alert
Stephen Liu

Stephen Liu on the AMAZE-lung Trial of Amivantamab, Lazertinib, and Bevacizumab in EGFR-Mutant NSCLC

Michael Dickinson, Lymphoma Symposium

Michael Dickinson Highlights Outcomes and CNS Relapse Patterns in High-Grade B-Cell Lymphoma

Eduardo Bruera

Eduardo Bruera Highlights Selective Use of Urine Drug Testing in Cancer Pain Clinics

Wafik S. El-Deiry

Wafik El-Deiry: Unraveling Cancer Plasticity and Histological Transformation in Precision Oncology

Lucia Santorelli

Lucia Santorelli: Landmark Study Uncovers Placental-Like Reprogramming in Early-Onset Colorectal Cancer

Sia Daneshmand

Sia Daneshmand: Combining Treatments to Improve Durable Responses in Non-Muscle-Invasive Bladder Cancer

OncoDaily Medical Journal

Breast Cancer

10.69690/ODMJ-001-1026-8231

Variable-Volume Oncoplastic Reconstruction Using a Modified Würinger Central Pedicle Technique for Upper Quadrants Breast Cancer: a single-center experience
Original Research

GI Oncology

10.69690/ODMJ-001-1026-8138

Association of Alpha-Fetoprotein and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Camrelizumab Plus Rivoceranib vs Sorafenib: Post Hoc Exploratory Analysis of the CARES-310 Trial
Original Research

Oncology Nursing

10.69690/ODMJ-002-0926-8087

Risk of Atrial Fibrillation in Breast Cancer Patients Treated with Radiotherapy: A Scoping Review
Reviews

Pediatric Oncology

10.69690/ODMJ-011-0826-7849

Integrated Management of Endo and Exo-pelvic Sacrococcygeal Teratomas (Altman type III): Report of Two Cases
Case Reports & Case Series

Oncology Nursing

10.69690/ODMJ-001-0826-7778

Real-World Patterns of Immune-Related Toxicity in Gastrointestinal Cancer Patients Treated with Immunotherapy: A service evaluation
Original Research

Oncology Nursing

10.69690/ODMJ-002-0826-7795

Late presentation in cancer care: Implications for treatment and survival: A Narrative Review
Reviews

GI Oncology

10.69690/ODMJ-018-0826-7959

From Plate to Polyps: Dietary N-Nitrosamines and Biomarkers of DNA Damage
Abstracts

Head and Neck Cancer

10.69690/ODMJ-018-0826-7933

A Service Review of PD-L1 Biomarker Use in the Head and Neck Cancer Service
Abstracts